article thumbnail

It’s Not Going to Be (Y)easy: What Happens when Business Collaborations Dissolve?

IPilogue

On October 25, 2022, following a string of antisemitic remarks and hate speech from Ye (formerly known as Kanye West) on social media, Adidas announced their decision to terminate their co-branding partnership with Ye and end production of all Yeezy branded products.

Business 131
article thumbnail

IP Protection of NFTs: A Comparative Look at the US and China

IP Tech Blog

The challenge becomes even bigger if NFTs are to be commercialized, exploited, and protected in different jurisdictions and at the same time — particularly when those markets include China, where protection for a foreign NFT creator or exploiter may face unique challenges. Therefore, DCs cannot be freely transacted in the Chinese market.

IP 109
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

IP Protection of NFTs: A Comparative Look at the US and China

LexBlog IP

The challenge becomes even bigger if NFTs are to be commercialized, exploited, and protected in different jurisdictions and at the same time — particularly when those markets include China, where protection for a foreign NFT creator or exploiter may face unique challenges. Tiffany created 250 NFTs and put them on the market.

IP 52
article thumbnail

TMSR Session 3: Private Actors…and their Machines

43(B)log

Adjudicators need to hear about risks of overenforcement, overclaiming; defenses—he gets emails from sellers of used or grey market goods snared in a robotic search. Other examples: design patent, as Sarah Burstein has writte n. User names on social media may or may not include trademarks; user bios give more information.

article thumbnail

A Look Back at India’s Top IP Developments of 2023

SpicyIP

Eventually, Johnson and Johnson announced that it would no longer enforce their patents for Bedaquiline (brand name: Sirturo) which is used in the treatment of multidrug-resistant tuberculosis (MDR-TB) in 134 low- and middle-income countries. Controller of Patents & Designs Patent Office Mumbai.

IP 124